SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001225208-17-014710
Filing Date
2017-09-06
Accepted
2017-09-06 17:56:46
Documents
1
Period of Report
2016-08-04

Document Format Files

Seq Description Document Type Size
1 doc4a.html 4/A  
1 doc4a.xml 4/A 3319
  Complete submission text file 0001225208-17-014710.txt   4801
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
AMBROSE ADELE D (Reporting) CIK: 0001182424 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-06571 | Film No.: 171072299